These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30235327)

  • 1. Molecular assays for antimalarial drug resistance surveillance: A target product profile.
    Nsanzabana C; Ariey F; Beck HP; Ding XC; Kamau E; Krishna S; Legrand E; Lucchi N; Miotto O; Nag S; Noedl H; Roper C; Rosenthal PJ; Schallig HDFH; Taylor SM; Volkman SK; Gonzalez IJ
    PLoS One; 2018; 13(9):e0204347. PubMed ID: 30235327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance.
    Wongsrichanalai C; Sibley CH
    Clin Microbiol Infect; 2013 Oct; 19(10):908-16. PubMed ID: 24033691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa.
    Watson OJ; Muchiri S; Ward A; Meier-Sherling C; Asua V; Katairo T; Brewer T; Cuomo-Dannenburg G; Winskill P; Bailey JA; Okell L; Scudu G; Woolsey AM
    medRxiv; 2024 Aug; ():. PubMed ID: 39252921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape.
    Nsanzabana C; Djalle D; Guérin PJ; Ménard D; González IJ
    Malar J; 2018 Feb; 17(1):75. PubMed ID: 29422048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa.
    Nsanzabana C
    Malar J; 2021 Oct; 20(1):401. PubMed ID: 34645475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in malaria.
    Parija SC; Praharaj I
    Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria medicines to address drug resistance and support malaria elimination efforts.
    Achan J; Mwesigwa J; Edwin CP; D'alessandro U
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):61-70. PubMed ID: 28965427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study.
    Ehrlich HY; Jones J; Parikh S
    Lancet Microbe; 2020 Sep; 1(5):e209-e217. PubMed ID: 33089222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
    Nsanzabana C
    Trop Med Infect Dis; 2019 Feb; 4(1):. PubMed ID: 30717149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance.
    Mwangi JM; Ranford-Cartwright LC
    Parasitology; 2013 Oct; 140(12):1455-67. PubMed ID: 23931581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination.
    Mathews ES; Odom John AR
    F1000Res; 2018; 7():. PubMed ID: 30135714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs.
    Abdul-Ghani R; Al-Maktari MT; Al-Shibani LA; Allam AF
    Acta Trop; 2014 Sep; 137():44-57. PubMed ID: 24801884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network.
    Cui L; Mharakurwa S; Ndiaye D; Rathod PK; Rosenthal PJ
    Am J Trop Med Hyg; 2015 Sep; 93(3 Suppl):57-68. PubMed ID: 26259943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
    Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary ARMS Race: Antimalarial Resistance Molecular Surveillance.
    Prosser C; Meyer W; Ellis J; Lee R
    Trends Parasitol; 2018 Apr; 34(4):322-334. PubMed ID: 29396203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).
    Raman J; Kagoro FM; Mabuza A; Malatje G; Reid A; Frean J; Barnes KI
    Malar J; 2019 Aug; 18(1):280. PubMed ID: 31438951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.